Patents by Inventor Kazuhiro Okochi

Kazuhiro Okochi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 9060941
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: June 23, 2015
    Assignees: ACTAVIS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Oral preparation comprising pioglitazone
    Patent number: 8865217
    Abstract: The present invention provides an oral preparation sufficiently masking the bitter taste of pioglitazone and a salt thereof. The present invention provides an oral preparation containing pioglitazone or a salt thereof and alkali metal chloride.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: October 21, 2014
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kazuhiro Okochi, Hiroyoshi Koyama, Arisa Maeda
  • Taste-masking solid preparation of pioglitazone
    Patent number: 8632808
    Abstract: A solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof; a solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof and having superior properties of superior disintegration property in the oral cavity, appropriate preparation strength, long-term preservation stability and the like is provided. The present invention provides a solid preparation comprising particles comprising (i) core particles comprising an excipient, and (ii) pioglitazone or a salt thereof and an acid-soluble polymer both coating the core particles.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: January 21, 2014
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kazuhiro Okochi, Arisa Maeda
  • Oral Preparation Comprising Pioglitazone
    Publication number: 20100136122
    Abstract: The present invention provides an oral preparation sufficiently masking the bitter taste of pioglitazone and a salt thereof. The present invention provides an oral preparation containing pioglitazone or a salt thereof and alkali metal chloride.
    Type: Application
    Filed: May 22, 2007
    Publication date: June 3, 2010
    Inventors: Kazuhiro Okochi, Hiroyoshi Koyama, Arisa Maeda
  • TASTE-MASKING SOLID PREPARATION OF PIOGLITAZONE
    Publication number: 20100034891
    Abstract: A solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof; a solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof and having superior properties of superior disintegration property in the oral cavity, appropriate preparation strength, long-term preservation stability and the like is provided. The present invention provides a solid preparation comprising particles comprising (i) core particles comprising an excipient, and (ii) pioglitazone or a salt thereof and an acid-soluble polymer both coating the core particles.
    Type: Application
    Filed: April 26, 2007
    Publication date: February 11, 2010
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Kazuhiro Okochi, Arisa Maeda
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20050226928
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 13, 2005
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Dual-chamber type injector and connector used therefor
    Patent number: 6224568
    Abstract: A needle connecting portion of a syringe which includes a drug accommodating chamber accommodating a first component is arranged opposite to a takeout port of a hermetically closed container which includes a container chamber accommodating a second component. The syringe is connected to the container through a connector so as to be movable in mutual proximity and adapted to be separable from the connector. There is provided a communication passage capable of communicating the drug accommodating chamber with the container chamber. The communication passage is cut off by a closure member arranged between both of the chambers. The syringe and the container chamber are moved in proximity to each other, thereby displacing the closure member so as to open the communication passage. An injector of the present invention is compact in shape but can surely retain sterility while being stored and surely mix both of the components accommodated therein through a simple operation just before administration.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: May 1, 2001
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Shuji Morimoto, Kazuhiro Okochi, Kotaro Wakamatsu, Nobuyoshi Tanaka